See the DrugPatentWatch profile for vascepa

Vascepa (generic name: icosapent ethyl) is a medication used to lower the risk of heart attacks and strokes in certain individuals. According to the drug's label, the most common adverse reactions (occurring in 2% or more of patients) during clinical trials were:

1. Influenza (flu) [1]
2. Musculoskeletal pain [1]
3. Abdominal pain [1]
4. Urinary tract infection [1]
5. Bronchitis [1]
6. Diarrhea [1]
7. Pain in extremity [1]

These adverse reactions were generally mild and did not result in discontinuation of the medication in the clinical trials. However, it is essential to consult a healthcare professional if any side effects are experienced while taking Vascepa.

Additionally, DrugPatentWatch.com does not provide information on adverse reactions. Instead, it focuses on drug patents, generics, and related market exclusivity data.

Sources:

1. [Vascepa (icosapent ethyl) capsules, for oral use. Full Prescribing Information. Amarin Pharma Inc.](https://www.vascepa.com/sites/default/files/Vascepa-PI-2021-03-26.pdf)